FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243636870> ?p ?o ?g. }

• W4243636870 endingPage "1273" @default.
• W4243636870 startingPage "1261" @default.
• W4243636870 abstract "Objective: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and zonisamide) in the treatment of children and adults with refractory partial and generalized epilepsies. Methods: A 23-member committee including general neurologists, pediatric neurologists, epileptologists, and doctors in pharmacy evaluated the available evidence based on a structured literature review including MEDLINE, Current Contents, and Cochrane library for relevant articles from 1987 until March 2003. Results: All of the new AEDs were found to be appropriate for adjunctive treatment of refractory partial seizures in adults. Gabapentin can be effective for the treatment of mixed seizure disorders, and gabapentin, lamotrigine, oxcarbazepine, and topiramate for the treatment of refractory partial seizures in children. Limited evidence suggests that lamotrigine and topiramate are also effective for adjunctive treatment of idiopathic generalized epilepsy in adults and children, as well as treatment of the Lennox Gastaut syndrome. Conclusions: The choice of AED depends upon seizure and/or syndrome type, patient age, concomitant medications, AED tolerability, safety, and efficacy. The results of this evidence-based assessment provide guidelines for the prescription of AEDs for patients with refractory epilepsy and identify those seizure types and syndromes where more evidence is necessary." @default.
• W4243636870 created "2022-05-12" @default.
• W4243636870 creator A5002880520 @default.
• W4243636870 creator A5008177310 @default.
• W4243636870 creator A5009468475 @default.
• W4243636870 creator A5009868672 @default.
• W4243636870 creator A5011301823 @default.
• W4243636870 creator A5016551006 @default.
• W4243636870 creator A5017041163 @default.
• W4243636870 creator A5024610687 @default.
• W4243636870 creator A5026925261 @default.
• W4243636870 creator A5032345248 @default.
• W4243636870 creator A5033855095 @default.
• W4243636870 creator A5040390968 @default.
• W4243636870 creator A5042209669 @default.
• W4243636870 creator A5043030502 @default.
• W4243636870 creator A5056282595 @default.
• W4243636870 creator A5060793900 @default.
• W4243636870 creator A5062446814 @default.
• W4243636870 creator A5065898901 @default.
• W4243636870 creator A5072563555 @default.
• W4243636870 creator A5075800477 @default.
• W4243636870 creator A5080677331 @default.
• W4243636870 creator A5084268690 @default.
• W4243636870 creator A5084486037 @default.
• W4243636870 creator A5085037662 @default.
• W4243636870 date "2004-04-26" @default.
• W4243636870 modified "2023-10-03" @default.
• W4243636870 title "Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED]" @default.
• W4243636870 doi "https://doi.org/10.1212/01.wnl.0000123695.22623.32" @default.
• W4243636870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15111660" @default.
• W4243636870 hasPublicationYear "2004" @default.
• W4243636870 type Work @default.
• W4243636870 citedByCount "318" @default.
• W4243636870 countsByYear W42436368702012 @default.
• W4243636870 countsByYear W42436368702013 @default.
• W4243636870 countsByYear W42436368702014 @default.
• W4243636870 countsByYear W42436368702015 @default.
• W4243636870 countsByYear W42436368702016 @default.
• W4243636870 countsByYear W42436368702017 @default.
• W4243636870 countsByYear W42436368702018 @default.
• W4243636870 countsByYear W42436368702019 @default.
• W4243636870 countsByYear W42436368702020 @default.
• W4243636870 countsByYear W42436368702021 @default.
• W4243636870 countsByYear W42436368702022 @default.
• W4243636870 countsByYear W42436368702023 @default.
• W4243636870 crossrefType "journal-article" @default.
• W4243636870 hasAuthorship W4243636870A5002880520 @default.
• W4243636870 hasAuthorship W4243636870A5008177310 @default.
• W4243636870 hasAuthorship W4243636870A5009468475 @default.
• W4243636870 hasAuthorship W4243636870A5009868672 @default.
• W4243636870 hasAuthorship W4243636870A5011301823 @default.
• W4243636870 hasAuthorship W4243636870A5016551006 @default.
• W4243636870 hasAuthorship W4243636870A5017041163 @default.
• W4243636870 hasAuthorship W4243636870A5024610687 @default.
• W4243636870 hasAuthorship W4243636870A5026925261 @default.
• W4243636870 hasAuthorship W4243636870A5032345248 @default.
• W4243636870 hasAuthorship W4243636870A5033855095 @default.
• W4243636870 hasAuthorship W4243636870A5040390968 @default.
• W4243636870 hasAuthorship W4243636870A5042209669 @default.
• W4243636870 hasAuthorship W4243636870A5043030502 @default.
• W4243636870 hasAuthorship W4243636870A5056282595 @default.
• W4243636870 hasAuthorship W4243636870A5060793900 @default.
• W4243636870 hasAuthorship W4243636870A5062446814 @default.
• W4243636870 hasAuthorship W4243636870A5065898901 @default.
• W4243636870 hasAuthorship W4243636870A5072563555 @default.
• W4243636870 hasAuthorship W4243636870A5075800477 @default.
• W4243636870 hasAuthorship W4243636870A5080677331 @default.
• W4243636870 hasAuthorship W4243636870A5084268690 @default.
• W4243636870 hasAuthorship W4243636870A5084486037 @default.
• W4243636870 hasAuthorship W4243636870A5085037662 @default.
• W4243636870 hasBestOaLocation W42436368701 @default.
• W4243636870 hasConcept C118552586 @default.
• W4243636870 hasConcept C126322002 @default.
• W4243636870 hasConcept C142724271 @default.
• W4243636870 hasConcept C187212893 @default.
• W4243636870 hasConcept C197934379 @default.
• W4243636870 hasConcept C204787440 @default.
• W4243636870 hasConcept C2775858608 @default.
• W4243636870 hasConcept C2776608144 @default.
• W4243636870 hasConcept C2776749334 @default.
• W4243636870 hasConcept C2777138316 @default.
• W4243636870 hasConcept C2777332695 @default.
• W4243636870 hasConcept C2777683783 @default.
• W4243636870 hasConcept C2778139780 @default.
• W4243636870 hasConcept C2778186239 @default.
• W4243636870 hasConcept C2778375690 @default.
• W4243636870 hasConcept C2778802184 @default.
• W4243636870 hasConcept C2779253243 @default.
• W4243636870 hasConcept C2780837902 @default.
• W4243636870 hasConcept C2781176495 @default.
• W4243636870 hasConcept C3018162438 @default.
• W4243636870 hasConcept C71924100 @default.
• W4243636870 hasConceptScore W4243636870C118552586 @default.
• W4243636870 hasConceptScore W4243636870C126322002 @default.
• W4243636870 hasConceptScore W4243636870C142724271 @default.
• W4243636870 hasConceptScore W4243636870C187212893 @default.
• W4243636870 hasConceptScore W4243636870C197934379 @default.

• next